BOOK YOUR TABLE75% floorspace sold...
limited seating left

Congratulations to all the Finalists!

The eyeforpharma Awards focus on what really matters: value for patients and customers. Recognizing innovative and meaningful approaches, this is the work worth applauding. Let’s deliver outcomes, restore pharma’s reputation and celebrate real achievements.

We’re delighted to announce the following companies have been shortlisted:

Most Valuable Healthcare/HCP Initiative

The winner of this award will be an innovative project which has delivered tangible working and healthcare improvements, both in the long and short term, to healthcare professionals or to healthcare institutions/systems.

  • Biomarin
    Title: A Global Rare Disease Education Campaign: Raising Suspicion of MPS Disorders and Sounding the Call for HCPs to Test Early
  • Bio-Med-Point
    Title: Bio-Medpoint’s new Coronary Artery Disease (CAD) detection system is set to revolutionize heart disease prevention
  • GSK
    Title: GSK PRO
  • Janssen
    Title: HealthCaring Conversations for Clinical Research
  • Radius
    Title: TYMLOS® First Responder
  • Novartis
    Title: Novartis American Academy of Ophthalmology Experience

Most Valuable Collaboration

The winner of this award will be the creator of a pharma-pharma or pharma-nonpharma initiative which clearly brings a new proposition to either HCPs, payers and/or healthcare systems, creates new value and redefines what is possible in our industry with a degree of lateral thinking.

  • MSD
    Title: SAS-HYPO-FIFE: Changing hypoglycaemic event management across Scotland
  • company
    Title: Takeda and Aptus Health: An enterprise approach to brand awareness and patient engagement by capitalizing on consumers’ preference for mobile
  • teva
    Title: Teva + Direct Relief Collaboration

Most Valuable Breakthrough/Discovery

This award is for an original product, product enhancement or scientific invention which has the potential and, ideally, early traction to provide significant impact on a patient population. The winner will be a genuine pioneer, bringing something novel and meaningful to the life sciences industry.

  • Alnylam
    Title: ONPATTRO®
  • AveXis
    Title: Zolgensma®
  • LEO-innovation-lab
    Title: LEO Innovation Lab: Imagine
  • nQ
    Title: neuroQWERTY
  • Sobi
    Title: Gamifant®
  • Insmed
    Title: ARIKAYCE®
  • EMD Serono
    Title: US FDA Approval: MAVENCLAD®

Most Promising MVP/Pilot

This award is for an experimental initiative which has the potential to disrupt the status quo. We are particularly keen to reward initiatives which have shown agility through the rapid creation of a product or service, bringing it into contact with real customers before being refined, and through smart measurement are able to preserve or pivot towards a finished project.

  • Allergan
    Title: Allergan Creates First-in-Category Digital Content Hub with the Launch of Spotlyte™
  • Ascencia
    Title: An Interconnected Diabetes Management Solution (IDMS) for People with T2D based on behavioral science
  • AstraZeneca
    Title: How Consolidative Technology Changed Sales Reps' Behaviours to Power Clinical Value-Based Selling
  • Biogen
    Title: Alzheimer’s Disease Patient Recruitment and Retention Team: An innovative and holistic approach to patient engagement and clinical trial recruitment in early Alzheimer’s Disease
  • Boehringer Ingelheim
    Title: Driving Timely, Relevant, and Informed Point of Care Conversation Between a Patient and their Doctor
  • DePuy-Synthes
    Title: OA MY WAY Program: JoinTogether Pilot

Most Promising Agile Transformation

This award is for an experimental initiative which has the potential to disrupt the status quo. We are particularly keen to reward initiatives which have shown agility through the rapid creation of a product or service, bringing it into contact with real customers before being refined, and through smart measurement are able to preserve or pivot towards a finished project.

  • Parexel
    Title: Configurable, Regulatory Grade Real World Data Platform
  • Biogen
    Title: Biogen BIIB093 in Large Hemispheric (LHI) Stroke Protocol Simulation: Ensuring each clinical research site team’s success in the first and subsequent patients at each site
  • Bristol-Myers-Squibb
    Title: BMS Innovation Accelerator - Driving innovation with speed and rigor together across the BMS enterprise
  • Merck
    Title: Merck's Mobile iLab53
  • UCB
    Title: UCB nPVU Internal Engine
  • Alexion
    Title: Alexion STAR

Most Valuable Clinical/Access Initiative

This award is for an initiative that has altered the traditional clinical development or market access pathway, ultimately finding ways for innovative treatments to reach patients more quickly and effectively, without compromising on quality and compliance.

  • Genetech
    Title: Launching the Genentech Patient Foundation
  • LEO-innovation-lab
    Title: LEO Innovation Lab: Studies&Me
  • Medicines-360
    Title: ACCESS IUS: Achieving Equity Through Diverse Clinical Trials
  • Pfizer
    Title: Embracing Patient Insights to Optimize Trial Design
  • Sanofi
    Title: PAIRED: Patient Informed Research & Development
  • vantage
    Title: Patient Group Pathway Model to Accessing Cancer Clinical Trials

Most Valuable Education Initiative

This award is for an initiative that has raised the profile and visibility of a disease, cause, health concern, population or treatment. We are not looking to reward mere advertising (no matter how good it is); we are seeking campaigns which have provided additional value, shown creative ways to raise awareness, gathered further reach in an additional way, clarified scientific concepts for HCPs or patients, or made things easier or clearer.

  • Abbvie
    Title: AbbVie Rheumatoid Arthritis and Psoriatic Arthritis Virtual Reality Experience
  • Janssen
    Title: Journey to Better Health Co-developed by Janssen and CISCRP
  • MSD
    Title: Networks in Anaesthesia and Surgery (NIAS) Global Meeting – Changing the Paradigm to Educate 1600 HCPs in 51 Countries”
  • Novo Nordisk
    Title: Cornerstones4Care Digital Sophia
  • UCB
    Title: The American Gastroenterological Association’s (AGA) IBD Parenthood Project, funded by UCB Pharma, a global biopharmaceutical company
  • Bayer
    Title: Using Technology to Connect Patients with Clinical Trials
  • Merck
    Title: Clinical Advances in Cancer Immunotherapy - A Collaboratively Developed Educational Initiative for Healthcare Professionals

Most Valuable Awareness Initiative

This award is for an initiative that has raised the profile and visibility of a disease, cause, health concern, population or treatment. We are not looking to reward mere advertising (no matter how good it is); we are seeking campaigns which have provided additional value, shown creative ways to raise awareness, gathered further reach in an additional way, clarified scientific concepts for HCPs or patients, or made things easier or clearer.

  • Bayer
    Title: Team PHenomenal Hope Brazil
  • Bristol-Myers-Squibb
    Title: Survivorship Today: What It’s Like to Live with Cancer
  • Horizon
    Title: #RARE is Education Awareness Initiative
  • Merck
    Title: A Touch of Sugar
  • Merck
    Title: “With Love, Me” Presented by Your Cancer Game Plan
  • Novartis
    Title: Generation S

Most Valuable Data & Insights Initiative

This award is for an initiative that harnesses data (internal or RWD), AI, ML or analytics to reveal valuable insights, ultimately resulting in new opportunities for better patient care. We are looking for those who have smartly deployed data or informatics/analysis techniques whether in clinical, commercial, medical or patient-generated data – or who have found ways through data standards or interoperability to enable better insights to be discovered and acted upon.

  • Catalia Health
    Title: How robotics and AI provide improved medication adherence and cost efficiencies
  • LEO-innovation-lab
    Title: LEO Innovation Lab: Imagine
  • physIQ
    Title: Using Machine Learning Analytics and Biosensor Data to Support Cancer Treatment
  • Sanofi
    Title: Innovative Medical Evidence Generation to Improve Patient Outcomes using DARWIN, Sanofi’s Real-World Data, Analytics and Machine Learning Platform
  • Takeda
    Title: Takeda R&D: Project Platypus
  • TransCelerate
    Title: TransCelerate BioPharma Inc.’s Placebo Standard of Care (PSoC) Initiative
  • ACTO
    Title: Using Learning and Sales Performance Data to Demonstrate Training’s Impact on Sales Outcomes
  • Alnylam
    Title: MSL Intelligence Platform

Most Valuable Service or Digital Therapy

This winner of this award will be an initiative which goes beyond the pill, providing a holistic service or solution that provides significant benefit to patients. The initiative may be complimentary to a medicine (perhaps referred Pill+ or a digital medicine) or be entirely independent of a medicine (for example a digital therapeutic), yet still able to demonstrate clinical or other value. It should either have launched, or will be launched imminently but with some in-field exposure.

  • amag
    Title: Women’s Sexual Health Chatbot
  • Annexus-Health
    Title: AssistPoint: Reducing the administrative burdens across the patient journey
  • ImagineCare
    Title: ImagineCare delivers 24/7 patient care that lowers costs and increase patient satisfaction
  • Medisafe
    Title: Medisafe Supports Adherence, Engagement and Improved Health Outcomes
  • Oshi-Health
    Title: Oshi Health, Inc. - the #1 all-in-one mobile app & platform for Inflammatory Bowel Disease
  • Saarathi-healthcare
    Title: Saarathi Healthcare
  • Takeda
    Title: Proactive digital symptom management to improve myeloma care in Finland

The Global Health Pioneer Award

This award is for a pioneering initiative that has made a significant improvement to the lives of those in emerging or developing economies, or underprivileged groups in developed economies. Initiatives may have either a local or regional impact. Ideally we are looking for an innovative approach that has changed the paradigm of care for an underprivileged population (although we acknowledge that, sometimes, straightforward efforts that recognize previously hidden/ignored communities can be just as worthy of recognition).

  • Medicines 360
    Title: Bridging Contraceptive Gaps for Women in Developing Countries
  • Takeda
    Title: Takeda R&D Access to Medicines Employee Fellowship Program
  • teva
    Title: Teva and Multiple Chronic Conditions

Patient Champion Award: Patient Advocate

The winner of this award will be a person or small group which identifies as a patient (or patient group), and who has provided other patients or people with a stronger voice, through advocacy work. This voice will have been influential enough to have created communities, changed policy, raised awareness, helped launch a product or driven a new movement.

  • Alicia Staley
    Alicia Staley Senior Director, Patient Engagement
    Medidata
  • Andra Stratton
    Andra Stratton President & Co-founder
    Lipodystrophy United
  • The Encephalitis Society
    The Encephalitis Society
  • Josh Robbins
    Josh Robbins Inspirational HIV Influencer
  • Michelle Rice
    Michelle Rice SVP, External Affairs
    National Hemophilia Foundation
  • ABRAF
    SOL-AR, a sun to breathe: tax exemption and solar-powered in-home oxygen for “electro-dependent” patients

Patient Champion Award: Pharma

The winner of this award will be an individual or small group which has demonstrably worked to make patient’s lives easier from within a pharmaceutical company, perhaps (but not necessarily) going against the grain of commercial interests, or forging a new path in order to champion or deliver a patient cause.

  • astellas
    Title: Mark Reisenauer, Senior Vice President of the Oncology Business Unit at Astellas, Astellas Oncology C3 Prize
  • GSK
    Title: Ian Marks, Champion of Selfcare
  • ferring
    Title: Development of Regional SOP to Improve Engagement with Patient Advocacy Groups
  • Novartis
    Title: Cosentyx Connect Personal Support Program
  • Novartis
    Title: Doing Everything Differently to Make a Difference
  • Pfizer
    Title: Developing plain language summaries of scientific congress abstracts: with patients, for patients

Entrepreneur Award: Patient Solution

The winner of this award will be a start-up company or entrepreneur who, in a short space of time, has generated strong traction with an original healthcare idea, product or service. We are especially keen on those who have found new ways to serve patients or health professionals in a beneficial way.

  • Enable-Injections
    Title: Enable Injections enFuse, Innovative On-Body Infusor with Vial Transfer System
  • Healthivibe
    Title: HealthiVibe, LLC.
  • illuminate-Health
    Title: Simplifying medication self-administration to increase adherence and wellness
  • Impel-Neuropharma
    Title: John Hoekman, Co-founder & Chief Scientific Officer of Impel Neuropharma
  • Saarathi-healthcare
    Title: Ranjeeta Vinil
  • Health Union
    Title: Health Union: Meaningful Patient Engagement to Help People Live Better with Challenging Health Conditions

Entrepreneur Award: Health Solution

The winner of this award will be a start-up company or entrepreneur who, in a short space of time, has generated strong traction with an original healthcare idea, product or service. We are especially keen on those who have found new ways to serve patients or health professionals in a beneficial way.

  • Annexus-Health
    Title: Reducing the burden across the patient journey
  • COTA
    Title: TBC
  • Medable
    Title: Medable - Dr. Michelle Longmire
  • Mercy-Research
    Title: An Innovative Approach to Community Health Based Research
  • PARX-Solutions
    Title: Meeting the Rx Prior Authorization Challenge, Improving Patient Access to Prescribed Meds
  • clover
    Title: Clover Therapeutics

Headline Sponsor

  • ZS

Media Partners

  • EMG-GOLD
  • Healthcare Sales Marketing
  • Pharmaceutical Executive
  • pharmaphorum
  • Pharmavoice
  • PMLiVE

Partners

  • digibooths
#efpAwards

eyeforpharma Awards is organised by eyeforpharma
Registered in England and Wales - Company registered number 09823909
7-9 Fashion Street, London, E1 6PX, UK
General Enquiries:
eswift@eyeforpharma.com | +44 (0) 207 375 7225

Sponsorship / Exhibition Enquiries:
rellis@eyeforpharma.com | +44 (0) 207 375 7170